NSE filing, NSE: DHANLAXMI. Summary written from the filing by ALFA Finder's alert engine.
Dhanlaxmi Crop Science Ltd: key numbers
- Share price
- ₹27.50
- Market cap
- ₹44.90 Cr
- Revenue (annual)
- ₹38.13 Cr
- Net profit (annual)
- ₹-0.49 Cr
- P/E (TTM)
- -91.3×Sector 22.8×
- Promoter holding
- 73.97%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dhanlaxmi Crop Science Ltd
All →Dhanlaxmi Crop Science Annual General Meeting
Dhanlaxmi Crop Science Limited held its 21st Annual General Meeting on September 30, 2026. Shareholders transacted ordinary and special business items.
Dhanlaxmi Crop Science Annual General Meeting
Dhanlaxmi Crop Science Limited has scheduled its 21st Annual General Meeting for September 30, 2026. The meeting will address the adoption of financial statements and director appointments.
Dhanlaxmi Crop Science Board Meeting Outcome
Dhanlaxmi Crop Science held a board meeting approving the 21st Annual General Meeting date, the Director's Report, and new director appointments.
Dhanlaxmi Crop Science Business Update
Dhanlaxmi Crop Science received regulatory approval to sell various hybrid and varietal field crop seeds in Chhattisgarh, strengthening its market presence in the region.
Dhanlaxmi Crop Science Other Announcement
Dhanlaxmi Crop Science Limited has appointed Fin portal Investments Private Limited as its Investor Relations agency effective August 1, 2026.
Dhanlaxmi Crop Science Results Update
Dhanlaxmi Crop Science reported FY26 revenue of ₹38.13 Crore, down from ₹129.30 Crore. Cotton segment headwinds impacted profitability, but management remains focused on crop diversification.
- Value
- ₹38.13 Cr
Other other announcement announcements
All →Robokidz Eduventures Other Announcement
Robokidz Eduventures filed its quarterly shareholding pattern for the period ended 30 September 2026. This is routine SEBI Regulation 31 disclosure with no transaction or corporate event.
Natco Pharma Other Announcement
Natco Pharma filed its shareholding pattern with a reporting date of 23 October 2026. Promoter and promoter group hold about 46% of total equity.
Innomet Advanced Materials Other Announcement
Innomet Advanced Materials filed its half-year Reg 32 statement on preferential issue proceeds, with no deviation. Rs.753.25 lakh raised in August 2026 was fully used for working capital.
CCME Global Other Announcement
CCME Global disclosed insider trades by two connected persons, acquiring 90 lakh and 22.5 lakh shares on 28 October 2026. Combined consideration is stated as Rs.112.50 Crore.
- Value
- ₹112.5 Cr
Jay Jalaram Technologies Other Announcement
Jay Jalaram Technologies named its KMP as authorised persons for materiality determination under Regulation 30. This administrative listing carries no financial or business impact.
SPR Auto Technologies Other Announcement
SPR Auto Technologies filed its quarterly QIP monitoring agency report for the quarter ended September 30, 2026. The report found no deviation from the issue objects.